Belimumab for the treatment of pediatric patients with lupus nephritis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Belimumab for the treatment of pediatric patients with lupus nephritis
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 23, Issue 3, Pages 243-251
Publisher
Informa UK Limited
Online
2023-02-08
DOI
10.1080/14712598.2023.2178297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Bayesian Reanalysis of the Phase III Aducanumab (ADU) Trial
- (2022) Tommaso Costa et al. JOURNAL OF ALZHEIMERS DISEASE
- Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus
- (2022) Stephen J. Balevic et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Safety and Efficacy of Belimumab in Patients with Lupus Nephritis
- (2022) Richard Furie et al. Clinical Journal of the American Society of Nephrology
- Effectiveness and safety of Belimumab combined with standard therapy in severe active lupus nephritis requiring kidney replacement therapy: A case report and literature review
- (2022) Chengning Zhang et al. Frontiers in Immunology
- Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients
- (2021) Kumutnart Chanprapaph et al. LUPUS
- Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint
- (2021) Tamer A Gheita et al. LUPUS
- LONG TERM RENAL SURVIVAL OF PEDIATRIC PATIENTS WITH LUPUS NEPHRITIS
- (2021) Selcan Demir et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered
- (2021) Rita Rubin JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Landmark Alzheimer’s drug approval confounds research community
- (2021) Asher Mullard NATURE
- EMBRACE: Phase 3/4, Randomized, 52‐Week Study of Belimumab Efficacy and Safety in Patients of Black African Ancestry With Systemic Lupus Erythematosus
- (2021) Ellen Ginzler et al. Arthritis & Rheumatology
- Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison
- (2021) Hermine I Brunner et al. RMD Open
- Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
- (2021) Muhammad Shipa et al. ANNALS OF INTERNAL MEDICINE
- Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort
- (2021) Mariele Gatto et al. JOURNAL OF AUTOIMMUNITY
- FDA Drug Approval and the Ethics of Desperation
- (2021) Emily A. Largent et al. JAMA Internal Medicine
- 2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
- (2020) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups
- (2020) J S Massias et al. LUPUS
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial
- (2020) Hermine I Brunner et al. ANNALS OF THE RHEUMATIC DISEASES
- CALIBRATE: A Phase 2 Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
- (2020) Yemil Atisha‐Fregoso et al. Arthritis & Rheumatology
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus
- (2020) Richard Dimelow et al. Clinical Pharmacology in Drug Development
- Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis
- (2019) Murray B Urowitz et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of belimumab plus standard therapy for up to 13 years in patients with systemic lupus erythematosus
- (2019) Daniel J Wallace et al. Arthritis & Rheumatology
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Effectiveness and safety of belimumab in patients with systemic lupus erythematosus in a real-world setting
- (2019) C Anjo et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Questions EMERGE as Biogen claims aducanumab turnaround
- (2019) Robert Howard et al. Nature Reviews Neurology
- Doubts persist for claimed Alzheimer's drug
- (2019) Kelly Servick SCIENCE
- A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
- (2018) Fengchun Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study
- (2018) Luca Iaccarino et al. JOURNAL OF AUTOIMMUNITY
- Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
- (2018) Antonis Fanouriakis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis
- (2018) Candace H. Feldman et al. Arthritis & Rheumatology
- First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL,Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)
- (2018) Bernardo A Pons-Estel et al. ANNALS OF THE RHEUMATIC DISEASES
- Epidemiology and management practices for childhood-onset systemic lupus erythematosus patients: a survey in Latin America
- (2018) Juliana C. O. A. Ferreira et al. CLINICAL RHEUMATOLOGY
- Subcutaneous formulation of belimumab in treatment of systemic lupus erythematosus: a critical review with focus on safety and satisfaction
- (2018) Hamdy Mohamed Abdelaziz Ahmed et al. Patient Preference and Adherence
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis
- (2017) Biswanath Basu et al. PEDIATRIC NEPHROLOGY
- Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study
- (2017) Zahi Touma et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Belimumab for the treatment of corticosteroid-dependent systemic lupus erythematosus: from clinical trials to real-life experience after 1 year of use in 48 Brazilian patients
- (2016) Morton Scheinberg et al. CLINICAL RHEUMATOLOGY
- Effects of Belimumab on Flare Rate and Expected Damage Progression in Patients With Active Systemic Lupus Erythematosus
- (2016) Luca Iaccarino et al. ARTHRITIS CARE & RESEARCH
- Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
- (2016) Ronald F. van Vollenhoven et al. Arthritis & Rheumatology
- Safety and Efficacy of Rituximab in Childhood-onset Systemic Lupus Erythematosus and Other Rheumatic Diseases
- (2015) A. Tambralli et al. JOURNAL OF RHEUMATOLOGY
- Safety and Efficacy of Belimumab to Treat Systemic Lupus Erythematosus in Academic Clinical Practices
- (2015) J. S. Hui-Yuen et al. JOURNAL OF RHEUMATOLOGY
- Clinical manifestations and survival among adults with (SLE) according to age at diagnosis
- (2014) JF Merola et al. LUPUS
- Baseline Predictors of Systemic Lupus Erythematosus Flares: Data From the Combined Placebo Groups in the Phase III Belimumab Trials
- (2013) Michelle A. Petri et al. ARTHRITIS AND RHEUMATISM
- Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
- (2013) E. M. Ginzler et al. JOURNAL OF RHEUMATOLOGY
- Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort
- (2013) E. M. McCarthy et al. RHEUMATOLOGY
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004
- (2012) Candace H. Feldman et al. ARTHRITIS AND RHEUMATISM
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
- (2012) MA Dooley et al. LUPUS
- The discovery and development of belimumab: the anti-BLyS–lupus connection
- (2012) William Stohl et al. NATURE BIOTECHNOLOGY
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors
- (2011) M. Kreuzaler et al. JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Early versus later onset childhood-onset systemic lupus erythematosus: Clinical features, treatment and outcome
- (2011) JS Hui-Yuen et al. LUPUS
- Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus
- (2011) D Pineles et al. LUPUS
- Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus
- (2011) Rina Mina et al. ARTHRITIS CARE & RESEARCH
- Prevalence and burden of pediatric-onset systemic lupus erythematosus
- (2010) Sylvia Kamphuis et al. Nature Reviews Rheumatology
- Markers of childhood lupus nephritis indicating disease activity
- (2010) Monika Edelbauer et al. PEDIATRIC NEPHROLOGY
- European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
- (2009) M. Mosca et al. ANNALS OF THE RHEUMATIC DISEASES
- Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus
- (2009) Aimee O. Hersh et al. ARTHRITIS AND RHEUMATISM
- B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients
- (2009) Sandy D. Hong et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Novel evidence-based systemic lupus erythematosus responder index
- (2009) Richard A. Furie et al. ARTHRITIS AND RHEUMATISM
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Clinical and Laboratory Characteristics and Long-Term Outcome of Pediatric Systemic Lupus Erythematosus: A Longitudinal Study
- (2007) Linda T. Hiraki et al. JOURNAL OF PEDIATRICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started